Harpoon Therapeutics, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    €27.50M +34.9% -€57.84M -59.7% -210.4% +4.9 pp -€76.54M -27.2% -278.3% +2.4 pp
    €20.38M +35.6% -€143.39M +258.9% -703.6% -4.4 pp -€105.16M +1,438.6% -516.0% -4.7 pp
    €15.03M +202.0% -€39.96M -10.8% -265.9% +6.3 pp -€6.83M -1,369.3% -45.5% -0.56 pp
    €4.98M +21.6% -€44.80M +90.0% -900.1% -3.2 pp €538.47K -102.4% 10.8% +5.7 pp
    €4.09M +570.9% -€23.58M +62.6% -576.1% +18 pp -€22.80M -763.4% -557.1% -11 pp
    €609.98K +∞% -€14.50M +47.6% -2,377.1% -24 pp €3.44M -139.0% 563.4% +5.6 pp
    €0.00 -€9.83M N/A -€8.82M N/A

    Notifications